Martos-Folgado I., del Monte-Monge A., Lorenzo C., Busse C.E., Delgado P., Mur S.M., Cobos-Figueroa L., Escolà-Gil J.C., Martín-Ventura J.L., Wardemann H., Ramiro A.R.. MDA-LDL vaccination induces athero-protective germinal-center-derived antibody responses. Cell Reports. 2022; 41(2)DOI:10.1016/j.celrep.2022.111468. PMID:36223741. IF:8.800(Q1/2D).

Gourdy, P, Bonadonna, RC, Freemantle, N, Mauricio, D, Muller-Wieland, D, Bigot, G, Mauquoi, C, Ciocca, A, Bonnemaire, M. Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis. Diabetes Therapy. 2022; 13(1)DOI:10.1007/s13300-021-01179-8. PMID:34784005. IF:3.800(Q2/5D).

Jayaraman, S, Perez, A, Minambres, I, Sanchez-Quesada, JL, Gursky, O. Heparin binding triggers human VLDL remodeling by circulating lipoprotein lipase: Relevance to VLDL functionality in health and disease. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS. 2022; 1867(1)DOI:10.1016/j.bbalip.2021.159064. PMID:34610468. IF:4.800(Q1/2D).

Chico, A, Corcoy, R. Intensive Insulin Therapy (Basal-Bolus). AMERICAN JOURNAL OF THERAPEUTICS. 2022; 29(1)DOI:10.1097/MJT.0000000000001152. PMID:33031154. IF:4.200(Q2/4D).

Puig-Jove, C, Castelblanco, E, Falguera, M, Hernandez, M, Soldevila, B, Julian, MT, Teis, A, Julve, J, Barranco-Altirriba, M, Franch-Nadal, J, Puig-Domingo, M, Ortega, E, Amigo, N, Alonso, N, Mauricio, D. Advanced lipoprotein profile in individuals with normal and impaired glucose metabolism. REVISTA ESPANOLA DE CARDIOLOGIA. 2022; 75(1)DOI:10.1016/j.recesp.2021.02.013. PMID:33785266. IF:5.900(Q1/3D).

Teis A., Castelblanco E., Cediel G., Amigó N., Julve J., Ribalta J., Guardiola M., Franch J., Bermúdez-López M., Codina P., Lupón J., Mauricio D., Alonso N., Bayés-Genís A.. Perfil lipoproteico por espectroscopia nuclear magnética en pacientes con insuficiencia cardiaca crónica comparado con controles emparejados. REVISTA ESPANOLA DE CARDIOLOGIA. 2022; 75(11)DOI:10.1016/j.recesp.2021.09.007. PMID:. IF:(Q/D).

Ramon, J, Llaurado, G, Guerri, R, Climent, E, Ballesta, S, Benaiges, D, Lopez-Montesinos, I, Navarro, H, Fernandez, N, Carrera, MJ, Mauricio, D, Flores-Le Roux, JA, Chillaron, JJ. Acute-to-Chronic Glycemic Ratio as a Predictor of COVID-19 Severity and Mortality. DIABETES CARE. 2022; 45(1)DOI:10.2337/dc21-1321. PMID:34782352. IF:16.200(Q1/1D).

Franch-Nadal J., Granado-Casas M., Mata-Cases M., Ortega E., Vlacho B., Mauricio D.. Determinants of response to the glucagon-like peptide-1 receptor agonists in a type 2 diabetes population in the real-world. Primary Care Diabetes. 2022; 16(6)DOI:10.1016/j.pcd.2022.10.005. PMID:36336605. IF:2.900(Q2/5D).

Genua I., Franch-Nadal J., Navas E., Mata-Cases M., Giménez-Pérez G., Vlacho B., Mauricio D., Goday A.. Obesity and related comorbidities in a large population-based cohort of subjects with type 1 diabetes in Catalonia. Frontiers in Endocrinology. 2022; 13DOI:10.3389/fendo.2022.1015614. PMID:36531459. IF:5.200(Q1/3D).

Pérez-Montes de Oca A., Julián M.T., Pera G., Caballería L., Morillas R., Torán P., Expósito C., Franch-Nadal J., Mauricio D., Alonso N.. Dysglycemia in young women attenuates the protective effect against fatty liver disease. Frontiers in Endocrinology. 2022; 13DOI:10.3389/fendo.2022.971864. PMID:36479218. IF:5.200(Q1/3D).

Moreno-Fernandez J., Chico A., Martínez-Brocca M.A., Beato-Víbora P.I., Vidal M., Piedra M., Quirós C., Muñoz-Rodríguez J.R.. Continuous Subcutaneous Insulin Infusion in Type 1 Diabetes Mellitus Patients: Results from the Spanish National Registry. Diabetes Technology & Therapeutics. 2022; 24(12)DOI:10.1089/dia.2022.0207. PMID:35947087. IF:5.400(Q1/3D).

Casas J.A.V., Sambo M., López C.L., Durán-Poveda M., García J.R.-V., Santos R.J., Llanos M., Navarro-González E., Aller J., Pubul V., Guadalix S., Crespo G., González C., Zafón C., Navarro M., Santamaría-Sandi J., Segura Á., Gajate P., Gómez-Balaguer M., Valdivia J., Puig-Domingo M., Galofré J.C., Castelo B., Villanueva M.J., Argüelles I., Orcajo-Rincón L.. Initial clinical and treatment patterns of advanced differentiated thyroid cancer: ERUDIT study. European Thyroid Journal. 2022; 11(5)DOI:10.1530/ETJ-21-0111. PMID:35900793. IF:4.700(Q2/3D).

Pérez Pérez A., Ortega Martínez de Victoria E., Arrieta Blanco F., Caixàs Pedragós A., Santos Mazo E., Fernández-Catalina P., Martínez-Hervas S., López-Medina J.A., Suárez-Gutiérrez L., Urgeles Planelles J.R., Gatell Menchén S., Tinahones Madueño F.. First clinical and efficacy data on evolocumab in routine clinical practice in endocrinology and nutrition services in Spain: a retrospective observational study (RETOSS-ENDO). Endocrinologia Diabetes y Nutricion. 2022; 69(7)DOI:10.1016/j.endinu.2021.07.009. PMID:35995680. IF:1.900(Q4/9D).

Tomic D., Morton J.I., Chen L., Salim A., Gregg E.W., Pavkov M.E., Arffman M., Balicer R., Baviera M., Boersma-van Dam E., Brinks R., Carstensen B., Chan J.C.N., Cheng Y.J., Fosse-Edorh S., Fuentes S., Gardiner H., Gulseth H.L., Gurevicius R., Ha K.H., Hoyer A., Jermendy G., Kautzky-Willer A., Keskimäki I., Kim D.J., Kiss Z., Klimek P., Leventer-Roberts M., Lin C.-Y., Lopez-Doriga Ruiz P., Luk A.O.Y., Ma S., Mata-Cases M., Mauricio D., McGurnaghan S., Imamura T., Paul S.K., Peeters A., Pildava S., Porath A., Robitaille C., Roncaglioni M.C., Sugiyama T., Wang K.-L., Wild S.H., Yekutiel N., Shaw J.E., Magliano D.J.. Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study. Lancet Diabetes & Endocrinology. 2022; 10(11)DOI:10.1016/S2213-8587(22)00252-2. PMID:36183736. IF:44.500(Q1/1D).

van Haalen F.M., Kaya M., Pelsma I.C.M., Cannegieter S.C., Huisman M.V., van Vlijmen B.J.M., Feelders R.A., Stochholm K., Fliers E., Castinetti F., Brue T., Bertherat J., Scaroni C., Colao A., Giordano R., Druce M.R., Beckers A., Spranger J., Driessens N., Maiter D., Feldt-Rasmussen U., Feelders R., Webb S.M., Dattani M., Husebye E., Zilaitiene B., Gaztambide S., Gatto F., Ferone D., Persani L., Chiodini I., Höybye C., Pereira A.M., Biermasz N.R., Klok F.A., Dekkers O.M., Meijer O.C., Reincke M., Vila G., Perry C., Heck A., Stancampiano M.R., van de Ven A., Johannsson G., Ragnarsson O., Tóth M., Volke V., Toumba M., Canu L., Vojtková J., Al-Mrayat M., Fassnacht M., Detomas M., Karavitaki N., van der Klauw M.M., Groselj U., Elenkova A., Unuane D.. Current clinical practice for thromboprophylaxis management in patients with Cushing’s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN). Orphanet Journal of Rare Diseases. 2022; 17(1)DOI:10.1186/s13023-022-02320-x. PMID:35505430. IF:3.700(Q2/4D).

Rivero-Sanchez, L, Gavric, A, Herrero, J, Remedios, D, Alvarez, V, Albeniz, E, Gordillo, J, Puig, I, Lopez-Vicente, J, Huerta, A, Lopez-Ceron, M, Salces, I, Penas, B, Parejo, S, Rodriguez, E, Herraiz, M, Carretero, C, Gimeno-Garcia, AZ, Saperas, E, Alvarez, C, Arnau-Collell, C, Ortiz, O, Sanchez, A, Jung, G, Balaguer, F, Pellise, M. The "diagnose and leave in" strategy for diminutive rectosigmoid polyps in Lynch syndrome: a post hoc analysis from a randomized controlled trial. ENDOSCOPY. 2022; 54(01)DOI:10.1055/a-1328-5405. PMID:33271604. IF:9.300(Q1/1D).

Batista, G, Marin-Jimenez, I, Fores, A, Garcia-Planella, E, Arguelles-Arias, F, Tagarro, I, Fernandez-Nistal, A, Montoto, C, Aparicio, J, Aguas, M, Santos-Fernandez, J, Bosca-Watts, MM, Ferreiro-Iglesias, R, Merino, O, Aldeguer, X, Corttes, X, Sicilia, B, Mesonero, F, Barreiro-de Acosta, M. Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNF alpha used for the treatment of IBD: Results from the VERNE study. DIGESTIVE AND LIVER DISEASE. 2022; 54(1)DOI:10.1016/j.dld.2021.06.005. PMID:34244110. IF:4.500(Q2/4D).

Zabana, Y, Marin-Jimenez, I, Rodriguez-Lago, I, Vera, I, Martin-Arranz, MD, Guerra, I, Gisbert, JP, Mesonero, F, Benitez, O, Taxonera, C, Ponferrada-Diaz, A, Piqueras, M, Lucendo, AJ, Caballol, B, Manosa, M, Martinez-Montiel, P, Bosca-Watts, M, Gordillo, J, Bujanda, L, Mancenido, N, Martinez-Perez, T, Lopez, A, Rodriguez-Gutierrez, C, Garcia-Lopez, S, Vega, P, Rivero, M, Melcarne, L, Calvo, M, Iborra, M, de-Acosta, MB, Sicilia, B, Barrio, J, Perez, JL, Busquets, D, Perez-Martinez, I, Navarro-Llavat, M, Hernandez, V, Argueelles-Arias, F, Esteso, FR, Meijide, S, Ramos, L, Gomollon, F, Munoz, F, Suris, G, de Zarate, JO, Huguet, JM, Llao, J, Garcia-Sepulcre, MF, Sierra, M, Dura, M, Estrecha, S, Coronel, AF, Hinojosa, E, Olivan, L, Iglesias, E, Gutierrez, A, Varela, P, Rull, N, Gilabert, P, Hernandez-Camba, A, Brotons, A, Ginard, D, Sese, E, Carpio, D, Aceituno, M, Cabriada, JL, Gonzalez-Lama, Y, Jimenez, L, Chaparro, M, Roman, ALS, Alba, C, Plaza-Santos, R, Mena, R, Tamarit-Sebastian, S, Ricart, E, Calafat, M, Olivares, S, Navarro, P, Bertoletti, F, Alonso-Galan, H, Pajares, R, Olcina, P, Manzano, P, Domenech, E, Esteve, M. Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry. Journal of Clinical Medicine. 2022; 11(2)DOI:10.3390/jcm11020421. PMID:35054116. IF:3.900(Q2/4D).

Semmler G., Lens S., Meyer E.L., Baiges A., Alvardo-Tapias E., Llop E., Tellez L., Schwabl P., Mauro E., Escudé L., Díez C., Ibañez-Samaniego L., Puente Á., Fortea J.I., Abadía M., Zanetto A., Conthe A., Hernandez-Évole H., Luzko Scheid I.S., Jia J., Yoshiji H., Francque S.M., Tsochatzis E.A., Russo F.P., Crespo G., Forns X., Bañares R., Villanueva C., Hernández-Gea V., Reiberger T., Bosch J., García Pagán J.C., Mandorfer M.. Non-invasive tests for clinically significant portal hypertension after HCV cure. JOURNAL OF HEPATOLOGY. 2022; 77(6)DOI:10.1016/j.jhep.2022.08.025. PMID:36063968. IF:25.700(Q1/1D).

Iborra M., Moret I., Busó E., García-Giménez J.L., Ricart E., Gisbert J.P., Cabré E., Esteve M., Márquez-Mosquera L., García-Planella E., Guardiola J., Pallardó F.V., Serena C., Algaba-Chueca F., Domenech E., Nos P., Beltrán B.. The Genetic Diversity and Dysfunctionality of Catalase Associated with a Worse Outcome in Crohn’s Disease. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(24)DOI:10.3390/ijms232415881. PMID:36555526. IF:5.600(Q1/3D).